Best Way To Test Dogs For Brucillosis

Lab Reagents

Human IgG antibody Laboratories manufactures the best way to test dogs for brucillosis reagents distributed by Genprice. The Best Way To Test Dogs For Brucillosis reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact dog brucellosis test. Other Best products are available in stock. Specificity: Best Category: Way Group: To Test

To Test information

WAY 200070
B7386-10 10 mg
EUR 202

WAY 200070
B7386-25 25 mg
EUR 393

WAY 200070
B7386-5 5 mg
EUR 131

WAY 200070
B7386-50 50 mg
EUR 615

WAY 316606
A3932-10 10 mg
EUR 586
Description: WAY 316606 is a selective small-molecule inhibitor of secreted frizzled-related protein-1 (sFRP-1) with EC50 value of 0.65 ?M [1].The Wnt signaling has been proved to be a drug target of treatment for metabolic bone diseases such as osteoporosis.

WAY 316606
A3932-100 100 mg
EUR 1958
Description: WAY 316606 is a selective small-molecule inhibitor of secreted frizzled-related protein-1 (sFRP-1) with EC50 value of 0.65 ?M [1].The Wnt signaling has been proved to be a drug target of treatment for metabolic bone diseases such as osteoporosis.

WAY 316606
A3932-5 5 mg
EUR 406
Description: WAY 316606 is a selective small-molecule inhibitor of secreted frizzled-related protein-1 (sFRP-1) with EC50 value of 0.65 ?M [1].The Wnt signaling has been proved to be a drug target of treatment for metabolic bone diseases such as osteoporosis.

WAY 316606
A3932-50 50 mg
EUR 1241
Description: WAY 316606 is a selective small-molecule inhibitor of secreted frizzled-related protein-1 (sFRP-1) with EC50 value of 0.65 ?M [1].The Wnt signaling has been proved to be a drug target of treatment for metabolic bone diseases such as osteoporosis.

WAY-100635
A3933-10 10 mg
EUR 155
Description: 5-HT1A receptors mediate various serotonergic functions and may be implicated in various pathologies including depressive and anxiety disorders, Alzheimer?s disease, and schizophrenia.

WAY-100635
A3933-200 200 mg
EUR 766
Description: 5-HT1A receptors mediate various serotonergic functions and may be implicated in various pathologies including depressive and anxiety disorders, Alzheimer?s disease, and schizophrenia.

WAY-100635
A3933-50 50 mg
EUR 466
Description: 5-HT1A receptors mediate various serotonergic functions and may be implicated in various pathologies including depressive and anxiety disorders, Alzheimer?s disease, and schizophrenia.

WAY-262611
B4818-10 10 mg
EUR 184

WAY-262611
B4818-5.1 10 mM (in 1mL DMSO)
EUR 205

WAY-262611
B4818-50 50 mg
EUR 506

WAY-600
B1641-10 10 mg
EUR 350
Description: WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308); selective for mTOR than PI3K? (>100-fold) and PI3K? (>500-fold).

WAY-600
B1641-200 200 mg
EUR 2217
Description: WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308); selective for mTOR than PI3K? (>100-fold) and PI3K? (>500-fold).

WAY-600
B1641-5 5 mg
EUR 268
Description: WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308); selective for mTOR than PI3K? (>100-fold) and PI3K? (>500-fold).